ScholarDeck

Cohort studyJournal of interventional cardiology · 2005

Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels?

Rita Ehrlich, Larisa Mutzmacher, Lea Averbuch … Refael Hirsh

NeurologyCohort study

Visual complaints after atrial septal defect closure had no transcranial Doppler abnormalities.

Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels?

Rita Ehrlich … Refael Hirsh

Journal of interventional cardiology · 2005

Background

Atrial septal defect (atrial septal defect) is a common diagnosis in young adults with congenital heart disease.

Purpose

The aim of this study was to determine if ocular symptoms following percutaneous treatment are due to microemboli.

45

Results

45

minutes

brain blood-flow monitoring found no abnormalities after visual symptoms

n = 20 adult

More results

The study group included 20 adult patients (9 men, 11 women, mean age 57.2 years) with atrial septal defect who had undergone successful closure with the Amplatzer occluder.

The patients were treated with aspirin or warfarin during 6 months after the procedure.

Ocular examination included the 120-point Humphrey visual field.

More results

Two patients complained of amaurosis fugax at 1 and 3 months after the procedure, and two patients complained of blurred vision at 3 and 4 months after the procedure.

“

Conclusion

Further studies in larger samples are needed to confirm these results.

Post

Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels?

Visual complaints after atrial septal defect closure had no transcranial Doppler abnormalities.

Related papers